DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Istari Oncology is a clinical-stage biotechnology company focused on developing innovative immuno-oncology platforms for the treatment of solid tumors, including glioblastoma and melanoma.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.